Grand finale to a fantastic #ASCO26! My @DukeCancer partner Dr. Jeff Shevach tells us about his research on a common African ancestry specific variant and its association with increased #prostatecancer risk. Important implications to improve PCa genetic testing for all patients
We know Black men are at higher risk for #prostatecancer & that a variant T allele increases their risk 3.4 x. The news: if someone has 2 of these T alleles, risk appears 11.4 x. Listen as McManus & Shevach discuss. #ASCO26 @DukeGUCancer @DukeCancer @DukeHealth
0
0
1
187
Hannah Dzimitrowicz McManus retweeted
#TaraSeibert killing it at her first #GU26. She starts her oncology fellowship at @DukeCancer in July. @AarmstrongDuke and @hannahdzmd have been her mentors. Help us recruit her to GU!
2
5
25
3,828
Hannah Dzimitrowicz McManus retweeted
#TumorBoardTuesday
☢️Radioligand therapy has tremendous potential to treat cancer🦀- we just need to know the right target🎯
📢Join us Tuesday, 01-13-26 at 🕰️8PM ET as
@AarmstrongDuke & @hannahdzmd 🗣️the use of PSMA-Lu177-617 therapy💡 in metastatic #prostatecancer
RT and brinssion‼️
☢️Radioligand therapy has tremendous potential to treat cancer🦀- we just need to know the right target🎯
📢Join us Tuesday, 01-13-26 at 🕰️8PM ET as
@AarmstrongDuke & @hannahdzmd 🗣️the use of PSMA-Lu177-617 therapy💡 in metastatic #prostatecancer
RT and brinssion‼️
1
5
14
1,734
Hannah Dzimitrowicz McManus retweeted
Join Dr Hannah McManus and I for a #TumorBoardTuesday on Jan 13th 8-9 pm ET! We will be discussing PSMA-Targeted Radioligand Therapy for Prostate Cancer. @DukeCancer @DukeGUCancer @hannahdzmd @PCFnews
0
4
13
1,314
Hannah Dzimitrowicz McManus retweeted
Federal #kidneycancer research funding drops from $50 million to ZERO after 57% cut to CDMRP. All but 12 of the 35 disease research programs saw funding eliminated for 2025, including the Kidney Cancer Research Program. More about the impact on our blog. bit.ly/4hoXnCq
1
19
16
6,357
Hannah Dzimitrowicz McManus retweeted
Great job @TiansterZhang discussing the moons of Jupiter and new advances in kidney cancer at #GU25 @ASCO !
0
3
14
975
Come check out our latest work in @IRONMANregistry evaluating PSA nadir and relationship to disease relapse in mHSPC at poster B11 #GU25
Hannah McManus presents update on IRONMAN registry data at #GU25. @hannahdzmd @DrPhilKantoff @DukeCancer
0
5
16
1,396
Hannah Dzimitrowicz McManus retweeted
Fantastic recognition for @Daniel_J_George @DukeGUCancer — recipient of this year’s Vogelzang humanitarian award!! @MattLabsMD @hannahdzmd @MRHarrisonMD @AarmstrongDuke please celebrate him when he gets home!
Congratulations to @Daniel_J_George for receiving the KCA's Nicholas J. Vogelzang Humanitarian Award! #IKCSNA24
2
4
48
5,121
Hannah Dzimitrowicz McManus retweeted
Check out our podcast reachmd.com/programs/proje… on treatment sequencing in mCRPC with @hannahdzmd based on this @pcan_journal article: pubmed.ncbi.nlm.nih.gov/39420184/
@DukeGUCancer
@DukeGUCancer
0
4
13
588
Excited to share our new review on Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey. @AarmstrongDuke @CaPsurvivorship @TDorffOnc @sartor_oliver @nealshore @pcan_journal
rdcu.be/dXjgg
rdcu.be/dXjgg
2
3
21
1,461
Thank you @GUconference for the opportunity to share our work in @IRONMANregistry demonstrating the ability to adapt guideline concordant care for #prostatecancer in the real world. Fantastic conference for learning, networking, and fun! @IDEOlogyHealth
Great start to @GUconference with an interactive poster session. @hannahdzmd discussing high uptake of combined therapy for mHSPC in @IRONMANregistry @loreleimucci
0
1
18
945
Hannah Dzimitrowicz McManus retweeted
Large @uk_biobank study confirmed many heritable gene-cancer associations. Shevach and @hannahdzmd explain how the new data underlines that ppl w many cancers types & THEIR FAMILIES should get genetic screening & that we must stop disparities in testing. @DukeCancer @kcooney1234
0
3
32
3,209
Hannah Dzimitrowicz McManus retweeted
Bittersweet last clinic day @UNCMedCenter after 10 years @UNC between college, residency, and fellowship. Seems like the right time to announce I’ll be joining @DukeGUCancer as faculty in July. Excited to get started! @Daniel_J_George @AarmstrongDuke @MattLabsMD @hannahdzmd
1
2
39
4,152
Hannah Dzimitrowicz McManus retweeted
The #WomeninOncology networking center has a wonderful line up at #ASCO24!
Privileged to join @KVanLoonMD @SuzanneColeMD #JeannyArahonChing #TriciaKalwar on Combating the Saboteurs panel
Join: 6/1 3:15-4pm in S502
& for all the programming & connections!
conferences.asco.org/am/womens-netw…
Privileged to join @KVanLoonMD @SuzanneColeMD #JeannyArahonChing #TriciaKalwar on Combating the Saboteurs panel
Join: 6/1 3:15-4pm in S502
& for all the programming & connections!
conferences.asco.org/am/womens-netw…
#WomenInOncology attending #ASCO24: Be sure to join us at the Women's Networking Center (Room S502) for inspiring panels and discussions! Open to women of all training levels.
Details ➡️ brnw.ch/21wKdHw
0
9
30
4,615
At #AACR2024 ? Come check out our poster examining uptake of guideline concordant mHSPC care in @IRONMANregistry . Rapid uptake of changing therapies and 86% rate overall📈. Important to develop quality benchmarks to ensure #prostatecancer patients getting best therapies.
0
2
11
490
Hannah Dzimitrowicz McManus retweeted
1/4 🚨 Time for a #TumorBoardTuesday extra! @AarmstrongDuke discusses developments w PARPi from #GU24:
- Sequence PARPi, vs w ARSI upfront?
- Which mutations benefit most from PARPi?
- Role for PARPi in castration sensitive #prostatecancer?
Keep scrolling for 📽️ updates👇
- Sequence PARPi, vs w ARSI upfront?
- Which mutations benefit most from PARPi?
- Role for PARPi in castration sensitive #prostatecancer?
Keep scrolling for 📽️ updates👇
2
5
9
2,004
Hannah Dzimitrowicz McManus retweeted
Wondering what to offer your NEPC/small cell prostate cancer patient after platinum chemo? Clinical trials but also perhaps lurbinectedin! See @DukeGUCancer poster with @AlanBryce9 showing activity. #GU2024
0
5
18
3,220
Hannah Dzimitrowicz McManus retweeted
Awesome start to #GU24 sharing our clinical and implementation outcomes using pluvicto at @DukeGUCancer with rising ⭐️s Valeria Maldonado Grijalva and Marybeth Nedrud, connecting with forever mentor/friend @TiansterZhang, and team bonding thanks to the GOAT @Daniel_J_George
1
3
31
1,485
Tune in and bring your questions tonight! Very excited to chat all things parp/arpi and #prostatecancer with @AarmstrongDuke Great way to start the week leading up to #GU24 @ASCO ! #bestweekever
#TumorBoardTuesday
There have been so many changes in the management of #prostatecancer ‼️
📢Join us Tonight, 01-23-2024 at🕰️8PM ET as @AarmstrongDuke and @hannahdzmd🗣️the use of PARP/ARPI combos in mCRPC
RT and bring others into the discussion‼️
0
5
17
2,006
Hannah Dzimitrowicz McManus retweeted
@StefiMorganti @nlinmd @drsarahsam @DFCI_BreastOnc @stolaney1 @curijoey @PTarantinoMD @ASCO Join us next week, January 23 as @hannahdzmd & @AarmstrongDuke discuss updates on the use of PARP inhibitors + androgen receptor pathway inhibitors (ARPI) in #prostatecancer!
1
3
5
602